Recombinant plsY is derived from Francisella philomiragia subsp. philomiragia (strain ATCC 25017) and produced in E. coli or mammalian cell systems . Key features include:
F. philomiragia is an opportunistic pathogen associated with near-drowning infections and granulomatous diseases . The plsY enzyme is implicated in bacterial membrane lipid synthesis, a potential therapeutic target. Studies show:
Macrophage Cytotoxicity: F. philomiragia exhibits strain-dependent cytotoxicity in murine and human macrophages .
Antimicrobial Resistance: Demonstrates increased resistance to human cathelicidin LL-37 compared to F. tularensis subsp. novicida, suggesting unique lipid membrane adaptations .
PlsY homologs exist in other Francisella species, such as F. tularensis subsp. tularensis (UniProt Q14H98), but differ in sequence and functional domains . The F. philomiragia variant shares 72% sequence identity with F. tularensis plsY, highlighting evolutionary conservation in lipid metabolism .
Recombinant plsY enables:
KEGG: fph:Fphi_1503
STRING: 484022.Fphi_1503
Glycerol-3-phosphate acyltransferase (plsY) is an essential enzyme in the bacterial phospholipid biosynthesis pathway. In Francisella philomiragia, plsY catalyzes the transfer of an acyl group from acyl-phosphate to glycerol-3-phosphate, creating lysophosphatidic acid (LPA), a critical intermediate in membrane phospholipid synthesis. The enzyme is also known as Acyl-PO4 G3P acyltransferase, GPAT, or LPA synthase. This initial acylation reaction is the first committed step in bacterial phospholipid biosynthesis and is essential for membrane formation and integrity . The plsY gene is conserved across Francisella species, including F. philomiragia, F. tularensis, and F. novicida, though with some sequence variations that reflect their evolutionary relationships .
For effective heterologous expression of Francisella proteins, including F. philomiragia plsY, E. coli expression systems with specific modifications are typically used. Standard protocols include:
Codon optimization for E. coli expression
Use of Francisella-specific promoters
Addition of affinity tags (commonly His-tag) for purification
The search results indicate that for Francisella proteins, "specific codon optimization for high-level plasmid-mediated protein expression" is required . Unlike many bacterial proteins, Francisella cannot effectively express proteins from standard E. coli plasmids without these modifications, as "Francisella cannot express exogenous Escherichia coli plasmids" .
For purification, the His-tagged recombinant protein approach has been successfully applied to F. tularensis proteins and would be suitable for F. philomiragia plsY as well .
The biochemical properties of plsY across Francisella species likely reflect their differing pathogenicity profiles. F. philomiragia is less virulent than F. tularensis, which might be partially attributed to differences in membrane composition resulting from variations in plsY activity or regulation.
While the search results don't provide specific biochemical comparison data for plsY across species, they do indicate that Francisella species differ in their virulence factors and protein expression patterns. Comparative proteomics studies have shown that "virulence factors... can be regulated by genes not contained in the FPI itself" , suggesting that metabolic enzymes like plsY could be differentially regulated between species with varying pathogenicity.
F. philomiragia has been reported to have a chromosomally encoded Class A carbapenemase gene, FPH-1, which provides broad-spectrum antibiotic resistance . This suggests that the genomic context in which plsY exists differs between species, potentially affecting its expression and function.
The substrate specificity of plsY determines which fatty acids are incorporated into bacterial membrane phospholipids, directly influencing membrane fluidity, permeability, and adaptation to environmental stresses. Although specific data on F. philomiragia plsY substrate preferences are not provided in the search results, research on other Francisella species offers valuable insights.
Francisella species can form biofilms, which "were shown to have increased AMR compared to planktonic cells" . The membrane composition, influenced by plsY activity, likely plays a role in biofilm formation and consequently impacts environmental persistence and antibiotic resistance. The membrane phospholipid composition may also affect the bacterium's ability to survive in diverse environments, from water sources to mammalian hosts.
An experimental approach to determine substrate specificity would involve:
Expression and purification of recombinant F. philomiragia plsY
In vitro enzymatic assays with various acyl-phosphate substrates
Analysis of reaction products by chromatography and mass spectrometry
Correlation of results with the natural phospholipid composition of F. philomiragia membranes
The role of plsY in antibiotic resistance mechanisms is complex and multifaceted. As a key enzyme in membrane biosynthesis, plsY activity directly influences membrane composition and potentially affects antibiotic penetration and efflux pump function.
Francisella species exhibit intrinsic resistance to many antibiotics "due to the nature of its LPS and the many enzymes it produces" . While plsY is not directly mentioned as an antibiotic resistance determinant in the search results, membrane-associated proteins and lipid metabolism have been implicated in antibiotic resistance in various bacteria.
F. philomiragia specifically "is reported to have a chromosomally encoded Class A carbapenemase gene, FPH-1" that "confers reduced susceptibility to imipenem" and provides "a broad spectrum of resistance, including expanded-spectrum cephalosporins, aztreonam, and carbapenems" . The interaction between this resistance mechanism and membrane lipid composition, which is influenced by plsY activity, represents an important area for investigation.
Based on the information for similar recombinant proteins from Francisella species, the following protocol would be recommended:
Expression System:
E. coli expression system with Francisella-specific promoters
N-terminal His-tag for purification
Expression at reduced temperatures (16-20°C) to enhance proper folding
Purification Protocol:
Cell lysis in Tris/PBS-based buffer, pH 8.0
Immobilized metal affinity chromatography (IMAC)
Size exclusion chromatography to remove aggregates
Storage in Tris/PBS-based buffer with 6% trehalose at pH 8.0
Storage Recommendations:
Store at -20°C/-80°C
Avoid repeated freeze-thaw cycles
For working aliquots, store at 4°C for up to one week
Add glycerol (final concentration 5-50%) for long-term storage
Reconstitution:
Centrifuge vial before opening
Reconstitute in deionized sterile water to 0.1-1.0 mg/mL
Add glycerol (recommended final concentration 50%) for aliquoting and long-term storage
Several transformation methods have been successfully used for introducing recombinant constructs into Francisella species, which could be adapted for plsY studies in F. philomiragia:
For F. philomiragia specifically, chemical competence or electroporation would likely be most suitable based on its genetic similarity to F. novicida.
Important considerations for genetic transformation include:
Use of Francisella-specific plasmid backbones (typically engineered from pFNL10)
Incorporation of Francisella-specific promoters for efficient expression
Selection of appropriate antibiotic resistance markers (avoiding those clinically useful for tularemia treatment, such as kanamycin)
Optimization of transformation conditions specific to F. philomiragia
In Vitro Enzymatic Assays:
Radiometric Assay: Measuring the incorporation of radiolabeled acyl groups into lysophosphatidic acid
Substrate: [14C]- or [3H]-labeled acyl-CoA or acyl-phosphate
Detection: Thin-layer chromatography followed by autoradiography or scintillation counting
Colorimetric/Fluorometric Assays: Measuring the release of inorganic phosphate or coenzyme A
Coupled enzyme assays where product formation is linked to a color-producing reaction
Suitable for high-throughput screening of inhibitors
Mass Spectrometry-Based Assays: Direct detection of reaction products
LC-MS/MS analysis of lysophosphatidic acid formation
Can detect multiple lipid species simultaneously to assess substrate specificity
In Vivo Activity Assessment:
Genetic Complementation: Testing whether F. philomiragia plsY can rescue growth of plsY-deficient E. coli or other Francisella species
Membrane Composition Analysis: Comparing phospholipid profiles between wild-type and plsY-modified strains
Growth Rate Analysis: Measuring growth under various conditions to assess the impact of plsY modifications
The essential role of plsY in bacterial membrane synthesis makes it an attractive target for antimicrobial development. A systematic approach to identify and develop inhibitors would include:
High-Throughput Screening (HTS):
Develop a miniaturized enzymatic assay suitable for screening compound libraries
Screen diverse chemical libraries, including natural product extracts
Identify hit compounds that inhibit plsY activity at low micromolar concentrations
Structure-Based Drug Design:
Determine the three-dimensional structure of F. philomiragia plsY through X-ray crystallography or cryo-EM
Use computational modeling to identify potential binding sites
Design compounds predicted to interact with catalytic or allosteric sites
Lead Optimization:
Establish structure-activity relationships through systematic modification of hit compounds
Improve potency, selectivity, and pharmacokinetic properties
Test optimized compounds against whole bacteria to confirm antimicrobial activity
Specificity Considerations:
Test activity against mammalian GPAT enzymes to ensure selectivity
Evaluate activity against diverse bacterial species to determine spectrum of activity
Assess potential for resistance development through long-term exposure studies
The immunogenic potential of F. philomiragia proteins, including plsY, represents an important research direction. Based on immunoproteomics studies of Francisella species, several approaches could be considered:
Evaluation as Vaccine Antigen:
Screen for antibody responses to plsY in recovered patients or animal models
Assess conservation across Francisella species to determine cross-protection potential
Evaluate cellular immune responses to plsY epitopes
The search results indicate that researchers have been "studying the antibody response to vaccination or infection with Francisella for many years" using methods such as "agglutination, ELISA, and 1D-Western blotting" . Modern approaches include "2D-Western blotting combined with protein identification by mass spectrometry" and "proteome microarray technology" that "prints recombinant proteins on glass slides to allow high throughput screening of immune sera" .
Diagnostic Applications:
Develop ELISA or other immunoassays using recombinant plsY
Evaluate sensitivity and specificity for detecting F. philomiragia infections
Compare antibody responses to plsY across different Francisella species infections
Proteome microarray studies have identified immunodominant proteins in Francisella that react with sera from infected individuals . By including F. philomiragia plsY in such arrays, its potential as a diagnostic marker could be assessed.
Functional genomics approaches offer powerful tools to investigate plsY's role in F. philomiragia biology:
Gene Knockout/Knockdown Studies:
Create conditional plsY mutants (as complete knockouts may be lethal)
Analyze phenotypic changes in growth, membrane composition, and stress responses
Assess impacts on biofilm formation and antibiotic susceptibility
Transcriptomic Analysis:
Compare gene expression profiles between wild-type and plsY-modified strains
Identify co-regulated genes that may function in related pathways
Analyze expression changes under different environmental conditions
Proteomic Approaches:
Comparative proteomics between F. philomiragia and other Francisella species
Identification of protein interaction partners using pull-down assays
Analysis of membrane proteome changes in plsY-modified strains
The search results mention a "comprehensive transposon-insertion library and a phenotype screen in F. novicida" that "confirmed the presence of intrinsic antibiotic resistance genes, and identified some genes that were not previously known to be involved in AMR" . Similar approaches could be applied to study plsY in F. philomiragia.
Despite the importance of plsY in bacterial phospholipid biosynthesis, several knowledge gaps remain:
Structural Characterization: The three-dimensional structure of F. philomiragia plsY has not been determined, limiting structure-based drug design efforts.
Regulation Mechanisms: How plsY expression and activity are regulated in response to environmental conditions remains poorly understood.
Host-Pathogen Interactions: Whether host immune responses specifically target plsY or its products during infection is unknown.
Environmental Adaptation: The role of plsY in adapting membrane composition to different environmental niches that F. philomiragia inhabits needs investigation.
Comparative Biology: Detailed biochemical comparisons between plsY from F. philomiragia and other Francisella species would enhance our understanding of species-specific adaptations.